Senores Pharmaceuticals Limited Share Price & Analysis
₹1,404▲ +1.37%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹1,404
+1.37%
Open
₹—
High
₹1,410
Low
₹1,368.7
Close
₹1,404
52W High
₹1,510
52W Low
₹601
Volume
131K
Lot Size
1
Sector
Healthcare
Market Cap
₹6K Cr
Face Value
₹10
Mid Cap
Price Chart
Fundamentals
P/E
56.1
Sector P/E
54.4
P/B
6.29
EPS
₹26.37
ROE
13.4%
ROCE
15.1%
D/E Ratio
0.35
Div Yield
0%
Book Value
₹203
+
Strengths
- ✓Efficient capital deployment (ROCE 15.1%)
- ✓Low debt relative to equity (D/E 0.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SENORES · as of Mar 2026
Promoters45.82%
FII3.64%▲0.29
DII9.62%▲0.30
Public40.92%▼0.62
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 45.77% | 45.78% | 45.78% | 45.80% | 45.81% | 45.82% |
| FII | 4.25% | 4.17% | 3.66% | 4.28% | 3.35% | 3.64% |
| DII | 11.77% | 9.66% | 9.51% | 8.62% | 9.32% | 9.62% |
| Public | 38.20% | 40.39% | 41.03% | 41.30% | 41.54% | 40.92% |
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
Results26 Jul 2026
Latest News
All news →Senores Pharmaceuticals publishes newspaper notice
Senores Pharmaceuticals Limited released a copy of its newspaper publication as part of regulatory compliance. The filing contains no financial or operational updates. Such disclosures are routine and typically informational in nature. No immediate market-moving developments were indicated. 📊 *STOCKS:* SENORES | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
NSE Filing3 Jul
Senores Pharma to host analyst and investor meet
*Senores Pharma to host analyst and investor meet.* The company has announced a schedule for its investor interaction. No financial updates or guidance changes were disclosed. Event aimed at enhancing institutional engagement. 📊 *STOCKS:* SENORES | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings
NSE Filing9 Jun
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹175 Cr ▲2.3% | ₹171 Cr ▲5.6% | ₹162 Cr ▲17.4% | ₹138 Cr ▲21.1% | ₹114 Cr ▲10.7% | ₹103 Cr ▲2.0% | ₹101 Cr ▲26.3% | ₹80 Cr |
| Op. Profit | ₹47 Cr ▼6.0% | ₹50 Cr ▲0.0% | ₹50 Cr ▲47.1% | ₹34 Cr ▲78.9% | ₹19 Cr ▼26.9% | ₹26 Cr ▲13.0% | ₹23 Cr ▲9.5% | ₹21 Cr |
| OPM | 27.0% ▼6.9% | 29.0% ▼6.5% | 31.0% ▲24.0% | 25.0% ▲47.1% | 17.0% ▼32.0% | 25.0% ▲8.7% | 23.0% ▼14.8% | 27.0% |
| Net Profit | ₹37 Cr ▲8.8% | ₹34 Cr ▲13.3% | ₹30 Cr ▲42.9% | ₹21 Cr ▲16.7% | ₹18 Cr ▲12.5% | ₹16 Cr ▲23.1% | ₹13 Cr ▲18.2% | ₹11 Cr |
| EPS (₹) | 6.86 ▼0.1% | 6.87 ▼2.3% | 7.03 ▲64.3% | 4.28 ▲10.6% | 3.87 ▲3.8% | 3.73 ▼3.4% | 3.86 ▲19.5% | 3.23 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | ₹633 Cr ▲59.0% | ₹398 Cr ▲85.1% | ₹215 Cr ▲514.3% | ₹35 Cr ▲150.0% | ₹14 Cr |
| Expenses | ₹464 Cr ▲50.2% | ₹309 Cr ▲78.6% | ₹173 Cr ▲652.2% | ₹23 Cr ▲91.7% | ₹12 Cr |
| Op. Profit | ₹168 Cr ▲86.7% | ₹90 Cr ▲114.3% | ₹42 Cr ▲223.1% | ₹13 Cr ▲550.0% | ₹2 Cr |
| OPM | 27.0% ▲17.4% | 23.0% ▲21.1% | 19.0% ▼47.2% | 36.0% ▲157.1% | 14.0% |
| Other Income | ₹47 Cr ▲147.4% | ₹19 Cr ▲533.3% | ₹3 Cr ▼25.0% | ₹4 Cr | ₹0 Cr |
| Interest | ₹25 Cr ▲13.6% | ₹22 Cr ▲144.4% | ₹9 Cr ▲350.0% | ₹2 Cr ▲100.0% | ₹1 Cr |
| Depreciation | ₹31 Cr ▲82.4% | ₹17 Cr ▲70.0% | ₹10 Cr ▲400.0% | ₹2 Cr ▲100.0% | ₹1 Cr |
| PBT | ₹159 Cr ▲123.9% | ₹71 Cr ▲184.0% | ₹25 Cr ▲108.3% | ₹12 Cr ▲1100.0% | ₹1 Cr |
| Tax % | 24.0% ▲41.2% | 17.0% ▲154.8% | -31.0% ▼196.9% | 32.0% ▲146.2% | 13.0% |
| Net Profit | ₹122 Cr ▲110.3% | ₹58 Cr ▲75.8% | ₹33 Cr ▲312.5% | ₹8 Cr ▲700.0% | ₹1 Cr |
| EPS (₹) | 25.05 ▲96.9% | 12.72 ▲23.4% | 10.31 ▲20.0% | 8.59 ▲750.5% | 1.01 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Liabilities | |||||
| Equity Capital | ₹46 Cr ▲0.0% | ₹46 Cr ▲48.4% | ₹31 Cr ▲210.0% | ₹10 Cr ▲11.1% | ₹9 Cr |
| Reserves | ₹888 Cr ▲20.0% | ₹740 Cr ▲325.3% | ₹174 Cr ▲383.3% | ₹36 Cr ▲28.6% | ₹28 Cr |
| Borrowings | ₹342 Cr ▲8.6% | ₹315 Cr ▲22.1% | ₹258 Cr ▲309.5% | ₹63 Cr ▲320.0% | ₹15 Cr |
| Other Liabilities | ₹328 Cr ▲160.3% | ₹126 Cr ▼21.3% | ₹160 Cr ▲595.7% | ₹23 Cr ▲187.5% | ₹8 Cr |
| Total Liabilities | ₹1.6K Cr ▲30.7% | ₹1.2K Cr ▲97.3% | ₹622 Cr ▲374.8% | ₹131 Cr ▲122.0% | ₹59 Cr |
| Assets | |||||
| Fixed Assets | ₹755 Cr ▲150.8% | ₹301 Cr ▲28.1% | ₹235 Cr ▲770.4% | ₹27 Cr ▲285.7% | ₹7 Cr |
| CWIP | ₹17 Cr ▼90.1% | ₹172 Cr ▲77.3% | ₹97 Cr ▲185.3% | ₹34 Cr ▲325.0% | ₹8 Cr |
| Investments | ₹4 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹16 Cr ▲6.7% | ₹15 Cr |
| Other Assets | ₹827 Cr ▲9.7% | ₹754 Cr ▲160.9% | ₹289 Cr ▲445.3% | ₹53 Cr ▲82.8% | ₹29 Cr |
| Total Assets | ₹1.6K Cr ▲30.7% | ₹1.2K Cr ▲97.3% | ₹622 Cr ▲374.8% | ₹131 Cr ▲122.0% | ₹59 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating CF | ₹62 Cr ▲234.8% | ₹-46 Cr ▼76.9% | ₹-26 Cr ▼2500.0% | ₹-1 Cr ▲90.0% | ₹-10 Cr |
| Investing CF | ₹-121 Cr ▲71.8% | ₹-429 Cr ▼694.4% | ₹-54 Cr ▼12.5% | ₹-48 Cr ▼100.0% | ₹-24 Cr |
| Financing CF | ₹-1 Cr ▼100.2% | ₹573 Cr ▲558.6% | ₹87 Cr ▲89.1% | ₹46 Cr ▲27.8% | ₹36 Cr |
| Net Cash Flow | ₹-60 Cr ▼161.2% | ₹98 Cr ▲1125.0% | ₹8 Cr ▲366.7% | ₹-3 Cr ▼250.0% | ₹2 Cr |
| Free Cash Flow | ₹-203 Cr ▲0.0% | ₹-203 Cr ▼160.3% | ₹-78 Cr ▼62.5% | ₹-48 Cr ▼128.6% | ₹-21 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Debtor Days | 187d ▲64.0% | 114d ▼40.3% | 191d ▼16.2% | 228d ▼54.9% | 506d |
| Inventory Days | 130d ▼44.0% | 232d ▲26.1% | 184d ▲106.7% | 89d ▼34.1% | 135d |
| Days Payable | 340d ▲23.6% | 275d ▼50.5% | 556d ▲43.3% | 388d ▲19.8% | 324d |
| Cash Conv. Cycle | -24d ▼134.3% | 70d ▲138.5% | -182d ▼156.3% | -71d ▼122.4% | 317d |
| Working Capital Days | 132d ▲50.0% | 88d ▲650.0% | -16d ▼128.6% | -7d ▼101.9% | 359d |
| ROCE | 15.0% ▲36.4% | 11.0% ▼8.3% | 12.0% ▼33.3% | 18.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Senores Pharmaceuticals Limited share price today?▾
Senores Pharmaceuticals Limited (SENORES) is currently trading at ₹1,404 on NSE, up 1.37% as of the last market session. Prices update daily after market close on MarketNetra.
Is Senores Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Senores Pharmaceuticals Limited (SENORES) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Senores Pharmaceuticals Limited 52-week high and low?▾
Senores Pharmaceuticals Limited's 52-week high is ₹1,510 and the 52-week low is ₹601. The current price of ₹1,404 is 7.0% below the 52W high.
What is Senores Pharmaceuticals Limited P/E ratio?▾
Senores Pharmaceuticals Limited's current P/E ratio is 56.1. This indicates the market is paying ₹56.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Senores Pharmaceuticals Limited options?▾
Senores Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SENORES options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.